Penserra Capital Management LLC Nautilus Biotechnology, Inc. Transaction History

Penserra Capital Management LLC

  • $7.96 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.64 - $4.84 $1,415 - $2,594
-536 Reduced 11.38%
4,175 $11,000
Q1 2022

May 13, 2022
SELL
$3.5 - $5.3 $4,018 - $6,084
-1,148 Reduced 19.59%
4,711 $20,000
Q4 2021

Feb 15, 2022
BUY
$4.45 - $6.21 $3,982 - $5,557
895 Added 18.03%
5,859 $30,000
Q3 2021

Nov 15, 2021
BUY
$6.14 - $10.1 $1,289 - $2,121
210 Added 4.42%
4,964 $30,000
Q2 2021

Aug 12, 2021
BUY
$9.04 - $14.19 $42,976 - $67,459
4,754 New
4,754 $48,000

Others Institutions Holding NAUT

# of Institutions
76
Shares Held
63.1M
Call Options Held
14K
Put Options Held
1.8K
View Full List

About Nautilus Biotechnology, Inc.

NAUT Quotes by TradingView
  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $349M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email